Cargando…
Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
BACKGROUND: Euchromatic histone-lysine-N-methyltransferases 1 and 2 (EHMT1/2, aka GLP/G9A) catalyze dimethylation of histone H3 lysine 9 (H3K9me2) and have roles in epigenetic silencing of gene expression. EHMT1/2 also have direct roles in DNA repair and are implicated in chemoresistance in several...
Autores principales: | Watson, Zachary L., Yamamoto, Tomomi M., McMellen, Alexandra, Kim, Hyunmin, Hughes, Connor J., Wheeler, Lindsay J., Post, Miriam D., Behbakht, Kian, Bitler, Benjamin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882350/ https://www.ncbi.nlm.nih.gov/pubmed/31775874 http://dx.doi.org/10.1186/s13148-019-0758-2 |
Ejemplares similares
-
De novo methylation of histone H3K23 by the methyltransferases EHMT1/GLP and EHMT2/G9a
por: Vinson, David A., et al.
Publicado: (2022) -
Histone Methyltransferases G9a/Ehmt2 and GLP/Ehmt1 Are Associated with Cell Viability and Poorer Prognosis in Neuroblastoma and Ewing Sarcoma
por: Souza, Barbara Kunzler, et al.
Publicado: (2023) -
TNFα Effects on Adipocytes Are Influenced by the Presence of Lysine Methyltransferases, G9a (EHMT2) and GLP (EHMT1)
por: Able, Ashley A., et al.
Publicado: (2023) -
Combinatory EHMT and PARP inhibition induces an interferon response and a CD8 T cell-dependent tumor regression in PARP inhibitor-resistant models
por: Nguyen, Lily L., et al.
Publicado: (2023) -
Distinct functions of EHMT1 and EHMT2 in cancer chemotherapy and immunotherapy
por: Kang, Zhihua, et al.
Publicado: (2023)